Innate Pharma SA (IPHA) stock
IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$1.03−0.30 (-22.56%)
Close on Nov 18, 2026Market cap $96.53MP/E –Yield –
Innate Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Innate Pharma's market cap was $142.45M on Nov 11, 2026, against $158.05M a year earlier. Over the last 5 years it ranged from $114.68M to $359.94M, with a median of $184.24M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $142.45M | +0.4% |
| 2025 | Dec 31, 2025 | $141.84M | -4.2% |
| 2024 | Dec 31, 2024 | $148.03M | -33.6% |
| 2023 | Dec 29, 2023 | $222.99M | -24.8% |
| 2022 | Dec 30, 2022 | $296.69M | -17.6% |
| 2021 | Dec 31, 2021 | $359.94M | +31.5% |
| 2020 | Dec 31, 2020 | $273.66M | -27.7% |
| 2019 | Dec 31, 2019 | $378.52M | – |
See a number that looks wrong?